Nuclear Factor-κB Decoys Suppress Endotoxin-Induced Lung Injury
Open Access
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Molecular Pharmacology
- Vol. 67 (4) , 977-979
- https://doi.org/10.1124/mol.105.011296
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Nuclear Factor-κB Decoy Oligodeoxynucleotides Prevent Acute Lung Injury in Mice with Cecal Ligation and Puncture-Induced SepsisMolecular Pharmacology, 2005
- Selective Blockade of NF-κB Activity in Airway Immune Cells Inhibits the Effector Phase of Experimental AsthmaThe Journal of Immunology, 2004
- NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosisProceedings of the National Academy of Sciences, 2004
- Missing Pieces in the NF-κB PuzzleCell, 2002
- The Beginning of the End: IκB Kinase (IKK) and NF-κB ActivationJournal of Biological Chemistry, 1999
- The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of ApoptosisThe Journal of Experimental Medicine, 1999
- A ubiquitin ligase complex essential for the NF-kappa B, Wnt/Wingless, and Hedgehog signaling pathwaysGenes & Development, 1999
- NF-κB as a Frequent Target for Immunosuppressive and Anti-Inflammatory Molecules**This article was accepted for publication on 27 September 1996.Published by Elsevier ,1997
- Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.Journal of Clinical Investigation, 1996
- IκB: a Specific Inhibitor of the NF-κB Transcription FactorScience, 1988